Therapeutic progress in rosacea: targeting the neuro-vascular-immune triad - Takeaways - MDSpire

Therapeutic progress in rosacea: targeting the neuro-vascular-immune triad

  • By

  • Xingyin Yang

  • Wanqing Yang

  • Nuoran Chen

  • Dansheng Li

  • Yang Xu

  • June 22, 2026

  • 0 min

Share

  • 1

    Rosacea is a chronic inflammatory skin condition primarily affecting the face, characterized by flushing, erythema, and telangiectasia.

  • 2

    The neuro-vascular-immune triad plays a crucial role in the pathogenesis of rosacea, influencing disease progression and symptoms.

  • 3

    Severe rosacea can lead to psychological issues such as anxiety and depression, significantly affecting patients' quality of life.

  • 4

    Emerging treatments targeting the neuro-vascular-immune triad include γ-aminobutyric acid derivatives, antidepressants, and neuromodulation techniques.

  • 5

    Current therapies lack large-scale randomized controlled trials, highlighting the need for further research on dosing regimens and treatment durations.

Original Source(s)

Related Content